Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxidative Stress | 10 | 2021 | 229 | 2.640 |
Why?
|
| Diaphragm | 11 | 2020 | 38 | 2.120 |
Why?
|
| Muscle, Skeletal | 9 | 2021 | 512 | 1.130 |
Why?
|
| Muscle Contraction | 4 | 2018 | 112 | 1.090 |
Why?
|
| Muscular Atrophy | 4 | 2020 | 71 | 0.970 |
Why?
|
| Systole | 1 | 2021 | 99 | 0.740 |
Why?
|
| Myocardium | 1 | 2021 | 185 | 0.690 |
Why?
|
| Free Radicals | 1 | 2019 | 9 | 0.680 |
Why?
|
| Molecular Imaging | 1 | 2019 | 20 | 0.670 |
Why?
|
| Muscle Weakness | 5 | 2020 | 37 | 0.660 |
Why?
|
| Oxidation-Reduction | 6 | 2021 | 268 | 0.660 |
Why?
|
| Mice, Knockout | 9 | 2021 | 443 | 0.640 |
Why?
|
| Mice | 15 | 2021 | 2474 | 0.630 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 9 | 0.620 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 1020 | 0.610 |
Why?
|
| Animals | 21 | 2021 | 7510 | 0.590 |
Why?
|
| Oxygen Consumption | 2 | 2018 | 154 | 0.550 |
Why?
|
| Heart Failure | 3 | 2019 | 639 | 0.510 |
Why?
|
| Reactive Oxygen Species | 5 | 2020 | 157 | 0.500 |
Why?
|
| Phrenic Nerve | 1 | 2014 | 4 | 0.490 |
Why?
|
| Respiration, Artificial | 3 | 2020 | 98 | 0.480 |
Why?
|
| Intraoperative Care | 1 | 2014 | 48 | 0.480 |
Why?
|
| Electric Stimulation | 1 | 2014 | 104 | 0.470 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 73 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 764 | 0.450 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 24 | 0.440 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1325 | 0.430 |
Why?
|
| Cachexia | 3 | 2020 | 7 | 0.400 |
Why?
|
| Physical Fitness | 1 | 2013 | 131 | 0.400 |
Why?
|
| Superoxide Dismutase | 3 | 2021 | 42 | 0.390 |
Why?
|
| Aging | 1 | 2018 | 943 | 0.380 |
Why?
|
| Adiposity | 1 | 2013 | 198 | 0.380 |
Why?
|
| Mitochondria | 5 | 2021 | 185 | 0.360 |
Why?
|
| Insulin Resistance | 1 | 2013 | 461 | 0.340 |
Why?
|
| Postoperative Complications | 1 | 2014 | 780 | 0.330 |
Why?
|
| Phosphorylation | 2 | 2021 | 228 | 0.300 |
Why?
|
| Physical Conditioning, Animal | 2 | 2018 | 32 | 0.300 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2019 | 5 | 0.290 |
Why?
|
| Male | 11 | 2021 | 19202 | 0.250 |
Why?
|
| Atrophy | 4 | 2020 | 46 | 0.230 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2020 | 7 | 0.230 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2021 | 78 | 0.220 |
Why?
|
| Calcium | 2 | 2021 | 306 | 0.200 |
Why?
|
| Ribosomal Proteins | 1 | 2021 | 4 | 0.190 |
Why?
|
| Ribosomes | 1 | 2021 | 10 | 0.190 |
Why?
|
| Hypertrophy | 1 | 2021 | 27 | 0.190 |
Why?
|
| Troponin I | 1 | 2021 | 22 | 0.190 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 25 | 0.190 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 34 | 0.190 |
Why?
|
| Aminoquinolines | 1 | 2020 | 16 | 0.190 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2020 | 4 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 68 | 0.180 |
Why?
|
| Benzamides | 1 | 2020 | 50 | 0.180 |
Why?
|
| Copper | 1 | 2020 | 12 | 0.180 |
Why?
|
| Fibrosis | 1 | 2021 | 120 | 0.180 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 65 | 0.180 |
Why?
|
| Organ Size | 1 | 2021 | 218 | 0.180 |
Why?
|
| Motor Neurons | 1 | 2020 | 40 | 0.180 |
Why?
|
| Zinc | 1 | 2020 | 32 | 0.180 |
Why?
|
| Female | 8 | 2021 | 19999 | 0.180 |
Why?
|
| Signal Transduction | 2 | 2021 | 680 | 0.170 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2019 | 1 | 0.170 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 27 | 0.160 |
Why?
|
| PPAR alpha | 1 | 2019 | 29 | 0.160 |
Why?
|
| Excitation Contraction Coupling | 1 | 2018 | 8 | 0.160 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 114 | 0.160 |
Why?
|
| Diabetic Retinopathy | 1 | 2019 | 65 | 0.160 |
Why?
|
| Rats | 5 | 2020 | 1592 | 0.150 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2017 | 9 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 251 | 0.140 |
Why?
|
| Physical Endurance | 1 | 2017 | 35 | 0.140 |
Why?
|
| Proteome | 1 | 2017 | 39 | 0.140 |
Why?
|
| Stroke Volume | 2 | 2019 | 348 | 0.140 |
Why?
|
| Proteomics | 1 | 2017 | 93 | 0.130 |
Why?
|
| Body Weight | 2 | 2018 | 309 | 0.130 |
Why?
|
| Echocardiography | 1 | 2015 | 158 | 0.120 |
Why?
|
| Humans | 7 | 2020 | 32082 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2015 | 165 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2015 | 507 | 0.110 |
Why?
|
| Exercise | 1 | 2019 | 672 | 0.110 |
Why?
|
| Monocrotaline | 1 | 2013 | 2 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2013 | 29 | 0.110 |
Why?
|
| Skinfold Thickness | 1 | 2013 | 7 | 0.110 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 22 | 0.110 |
Why?
|
| Eating | 1 | 2013 | 74 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 71 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2013 | 57 | 0.100 |
Why?
|
| Homeostasis | 1 | 2013 | 132 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 462 | 0.100 |
Why?
|
| Regeneration | 1 | 2013 | 170 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 473 | 0.090 |
Why?
|
| Sex Factors | 1 | 2013 | 667 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2017 | 288 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2020 | 135 | 0.090 |
Why?
|
| Inflammation | 1 | 2013 | 529 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2019 | 79 | 0.070 |
Why?
|
| Phenotype | 2 | 2020 | 632 | 0.070 |
Why?
|
| Antioxidants | 2 | 2018 | 114 | 0.070 |
Why?
|
| Child | 1 | 2013 | 2439 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 742 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 2017 | 59 | 0.060 |
Why?
|
| Gene Expression | 2 | 2018 | 337 | 0.060 |
Why?
|
| Adolescent | 1 | 2013 | 3568 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 45 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 6 | 0.050 |
Why?
|
| Mitochondria, Muscle | 1 | 2020 | 18 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 725 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 62 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 61 | 0.050 |
Why?
|
| Tetrazoles | 1 | 2020 | 61 | 0.050 |
Why?
|
| Imidazoles | 1 | 2020 | 91 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 261 | 0.040 |
Why?
|
| Middle Aged | 1 | 2014 | 11834 | 0.040 |
Why?
|
| Benzylidene Compounds | 1 | 2019 | 7 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2019 | 18 | 0.040 |
Why?
|
| Rats, Inbred BN | 1 | 2019 | 31 | 0.040 |
Why?
|
| Glutathione Reductase | 1 | 2018 | 9 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2019 | 20 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2018 | 16 | 0.040 |
Why?
|
| Retina | 1 | 2019 | 61 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2018 | 38 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 1187 | 0.040 |
Why?
|
| Neurons | 1 | 2021 | 407 | 0.040 |
Why?
|
| Cytosol | 1 | 2017 | 25 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2017 | 14 | 0.040 |
Why?
|
| Solubility | 1 | 2017 | 35 | 0.040 |
Why?
|
| Apoptosis | 1 | 2019 | 353 | 0.040 |
Why?
|
| Kinetics | 1 | 2017 | 208 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 66 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2016 | 5 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2016 | 2 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2016 | 9 | 0.030 |
Why?
|
| Superoxides | 1 | 2016 | 19 | 0.030 |
Why?
|
| Calpain | 1 | 2016 | 13 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 43 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 84 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 170 | 0.030 |
Why?
|
| Muscle Fatigue | 1 | 2013 | 12 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2013 | 3 | 0.030 |
Why?
|
| Tropomyosin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2013 | 20 | 0.030 |
Why?
|
| Respiratory Muscles | 1 | 2013 | 6 | 0.030 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2013 | 29 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 2282 | 0.030 |
Why?
|
| Actins | 1 | 2013 | 51 | 0.030 |
Why?
|
| Extremities | 1 | 2013 | 50 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 35 | 0.030 |
Why?
|
| Muscle Development | 1 | 2013 | 49 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 263 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2013 | 89 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2013 | 107 | 0.030 |
Why?
|
| Troponin | 1 | 2013 | 106 | 0.030 |
Why?
|
| Calcinosis | 1 | 2013 | 146 | 0.030 |
Why?
|
| Macrophages | 1 | 2013 | 188 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 534 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 2145 | 0.020 |
Why?
|